Labshake search
Citations for Tocris :
1 - 50 of 821 citations for Rat Nuclear Receptor Subfamily 4 Group A Member 2 NR4A2 ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Biophysics 2022Quote: ... 100 μM 2-APB blocking stretch-activated inositol triphosphate receptors (InsP3Rs) on the ER/nuclear membranes (Tocris Bioscience #1224), 100 μM CK-666 (Tocris Bioscience #3950 ...
-
bioRxiv - Neuroscience 2024Quote: ... a third group of animals were treated as those in group 2 with the addition of CB1 receptor antagonist AM251 (1 µM) (Tocris Bioscience, Bristol, UK). After 8 DIV ...
-
bioRxiv - Neuroscience 2020Quote: ... The bath solution for recordings contained elevated concentrations of divalent cations [4 mM Ca2+ and 4 mM Mg2+] and NMDA receptor antagonist 3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) [5 mM] (Tocris biosciences, 126453-07-4). Slices were used 1.5–4.5 hours after preparation ...
-
bioRxiv - Neuroscience 2024Quote: ... BIBP-3226 (Y1 receptor antagonist, 1-2 μM), and BIIE-0246 (Y2 receptor antagonist, 1-2 μM) were obtained from Tocris.
-
Pathogenic CD8 T cell responses are driven by neutrophil-mediated hypoxia in cutaneous leishmaniasisbioRxiv - Immunology 2023Quote: ... the sections were counter-stained with the nuclear probe 4’,6-diamino-2-phenylindole (DAPI, Biotechne-Tocris, UK). Slides were covered with Prolong™ Gold Antifade Mountant (Invitrogen ...
-
bioRxiv - Neuroscience 2022Quote: ... The CB1 receptor agonist WIN55,212-2 (WIN, Tocris #1038) was applied at a concentration of 1 µM as indicated ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Neuroscience 2021Quote: ... an agonist of group II metabotropic glutamate receptors (mGluR2/3) that reduces release probability in mossy fiber terminals (1 μM, Tocris)(Kamiya et al. ...
-
bioRxiv - Neuroscience 2022Quote: ... the AMPA/NMDA receptor agonist kynurenic acid (2 mM) and the GABA-A receptor antagonist picrotoxin (PTX; 100 uM, Tocris) were present ...
-
bioRxiv - Molecular Biology 2022Quote: ... DSBs were induced at the LacO array by inducing the nuclear localization (4-Hydroxytamoxifen (4-OHT, 100 nM, #3412, Tocris)) and stabilization (Shield-1 ligand ...
-
bioRxiv - Neuroscience 2022Quote: ... and L-2-amino-5-phosphonopentanoic acid (APV, an NMDA receptor blocker) from Tocris. APV ...
-
bioRxiv - Neuroscience 2019Quote: ... glycine receptors (GlyR) and GABAB receptors 10 μM (−)Bicuculline methiodide (Tocris Bioscience), 2 μM Strychnine hydrochloride (Tocris Bioscience ...
-
bioRxiv - Cell Biology 2020Quote: ... 2-(4-chlorophenyl)-3-methyl-N-(thiazole-2-yl)butanamide (4-CMTB; Tocris) was used as a FFAR2-specific agonist and AR420626 (Cayman ...
-
bioRxiv - Cell Biology 2021Quote: ... and human vasopressin type 2 receptor (V2R) with [Arg8]-vasopressin (AVP; Tocris 2935, in water). The transfected β-arrestins are of bovine origin ...
-
bioRxiv - Cancer Biology 2021Quote: ... 4 μM IWP-2 (Tocris), and 1 μM A83-01 (Tocris) ...
-
bioRxiv - Neuroscience 2019Quote: ... yohimbine (2–4 µM; Tocris). Endogenous dopamine levels were manipulated with the DAT inhibitor GBR-12909 (10 µM ...
-
bioRxiv - Developmental Biology 2020Quote: ... 4 μM IWP-2 (Tocris), and 1 μM A83-01 (Tocris ...
-
bioRxiv - Neuroscience 2021Quote: ... 3-((±)2-carboxypiperazin-4yl) propyl-1-phosphate (CPP, NMDA receptor antagonist, 20 μM; Tocris Bioscience, UK) and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX ...
-
bioRxiv - Neuroscience 2022Quote: ... we slowly infused 200 nl of the GABAA receptor agonist muscimol (Tocris; 2 μM in saline) into the target area using a micro-syringe pump (KD Scientific ...
-
bioRxiv - Physiology 2024Quote: ... injected with 2 mg/kg acylated rat ghrelin (1465, Tocris) solubilized in PBS using an injection volume of 2 mL/kg body weight ...
-
bioRxiv - Cell Biology 2021Quote: ... CBA (4-chloro-2-[[2-(2-chlorophenoxy) acetyl aminobenzoic acid from Tocris Bioscience (Minneapolis ...
-
bioRxiv - Neuroscience 2021Quote: ... IP3 receptors were blocked by bath application of 2-APB (100 µM, Tocris, Germany, micro-perfusion pump), 2-APB was applied at least 15 min prior t-LTP induction and was present throughout the recordings ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Neuroscience 2019Quote: ... LY341495 (group II mGluR; Tocris), MK-801 (NMDA receptors ...
-
bioRxiv - Neuroscience 2020Quote: ... 1-[2-(4-Methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl-1H-imidazole hydrochloride (SKF-96365; 1147, Tocris) in ddH20 ...
-
bioRxiv - Neuroscience 2019Quote: ... a final group of animals (n=4) received a DBB infusion of K-234 (1 nmol/0.5 µl/per side; Tocris Bioscience ...
-
bioRxiv - Cell Biology 2020Quote: ... or blockers of receptors associated with OxPC activity including platelet activating factor receptor (WEB-2086, Tocris 2339), prostaglandin EP2 receptor (PF-04418948 ...
-
bioRxiv - Neuroscience 2023Quote: ... 2 CaCl2 and 4 MNI-glutamate (Tocris). aCSF was continually bubbled with 95%O2 and 5%CO2 ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 μM 6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531; GABAA receptor antagonist, all from Tocris). The resting membrane potential was measured after whole-cell configuration was achieved ...
-
bioRxiv - Neuroscience 2021Quote: ... the group 2/3 mGluR agonist (DCG-IV) and MNI-glutamate for uncaging experiments were purchased from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2023Quote: ... WT mice were infected with 105 pfu of MA-10 SARS-CoV-2 in the presence of placebo or CGRP-receptor antagonist olcegepant slow-release pellets (olcegepant, BIBN4096, Tocris; 2 mg/kg/day/SQ) or mice lacking CGRP were infected with the same virus ...
-
bioRxiv - Neuroscience 2023Quote: ... WT mice were infected with 105 pfu of MA-10 SARS-CoV-2 in the presence of placebo or CGRP-receptor antagonist olcegepant slow-release pellets (olcegepant, BIBN4096, Tocris; 2 mg/kg/day/SQ) or mice lacking CGRP were infected with the same virus ...
-
bioRxiv - Neuroscience 2019Quote: ... To block NMDA receptors we used D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris, 10 μM final concentration). To block glycinergic inhibition ...
-
bioRxiv - Cell Biology 2020Quote: ... prostaglandin EP2 receptor (PF-04418948, Tocris 4814), CD36 [sulfosuccinimidyl oleate (SSO) ...
-
bioRxiv - Immunology 2019Quote: ... Adenosine receptor drugs were purchased from Tocris or Sigma Aldrich ...
-
bioRxiv - Immunology 2021Quote: ... and AT1 receptor antagonist Candesartan cilexetil (Tocris) were used in this study ...
-
bioRxiv - Immunology 2022Quote: ... the CCR3 receptor antagonist SB328437 (Tocris Bioscience) was added at a final concentration of 10 μM (41) ...
-
bioRxiv - Neuroscience 2023Quote: ... GABAB receptor antagonist CGP55845 (3 μM, Tocris), Na+ channel blocker tetrodotoxin (TTX ...
-
bioRxiv - Biochemistry 2023Quote: ... SKF81297 hydrobromide (D1-like receptor agonist, TOCRIS), quinpirole hydrochloride (D2-like receptor agonist ...
-
bioRxiv - Biochemistry 2023Quote: ... SCH 39166 (D1-like receptor antagonist, TOCRIS), raclopride (D2-like receptor antagonist ...
-
bioRxiv - Biochemistry 2023Quote: ... quinpirole hydrochloride (D2-like receptor agonist, TOCRIS), SCH 39166 (D1-like receptor antagonist ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 µM 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531;GABAA receptor antagonist; all from Tocris Bioscience).
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... 2-[[6-amino-3,5-dicyano-4-[4-(cyclopropylmethoxy) phenyl]-2-pyridinyl]thio]-acetamide (BAY 60-6583; Tocris, 910487-58-0), 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-β-D-ribofuranuronamide (2-Chloro-IB-MECA ...
-
bioRxiv - Neuroscience 2019Quote: ... The receptor-selective agonists we used included SKF 81297 for D1-like receptors (10–50 µM; Tocris, Minneapolis, MN); quinpirole for D2-like receptors (10–50 µM ...
-
bioRxiv - Neuroscience 2021Quote: Potassium currents were isolated pharmacologically during whole-cell voltage-clamp recordings by blocking fast sodium and calcium channels as well as ionotropic receptors for GABA and glutamate (2 µM tetrodotoxin (TTX, Tocris), 300 µM NiCl2 ...
-
bioRxiv - Neuroscience 2024Quote: ... another group of animals received an ip injection of WIN55,212-2 (0.5 mg/kg) along with CB1 receptor antagonist SR141716A (0.5 mg/kg, ip) (Tocris Bioscience, Bristol, UK). Rats were randomly selected for each group ...
-
bioRxiv - Neuroscience 2023Quote: ... (S)-2-Amino-2-methyl-4-phosphonobutanoic acid (MAP4; 250 µM; Tocris, Item# 0711), Tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2020Quote: ... co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris; 20 μM) (n=13) ...
-
bioRxiv - Neuroscience 2019Quote: ... and 2-(4-morpholino)-8-phenyl-4H-1-benzopyran-4-one (LY294002, 10µM) (Tocris) were dissolved in DMSO and then added in the external solution at a final concentration of DMSO of 0.001-0.04% ...
-
bioRxiv - Neuroscience 2020Quote: ... N-methyl D-aspartate (NMDA) receptors were blocked by the non-competitive NMDA receptor antagonist MK-801 (Tocris; 100 μM), co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris ...